Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-25-002914
Filing Date
2025-11-07
Accepted
2025-11-07 11:13:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6859
2 exhibit99.txt EX-99 2905
  Complete submission text file 0000315066-25-002914.txt   11710
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 0000

Mailing Address 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 3020 CALLAN ROAD SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Subject) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91534 | Film No.: 251461165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)